Fibrocell Science has submitted an Investigational New Drug Application (IND) with the FDA for a gene therapy candidate to treat moderate to severe localized scleroderma. Fibrocell Science has ...

MADISON, Wis. - A year ago, Chuck Beschta couldn't walk more than a few minutes without stopping to rest. "Just going out and doing normal activities outside like raking the lawn, mowing the grass, ...

There is new hope for patients with a rare autoimmune disorder. In mild cases, scleroderma causes areas of hardened skin. But in severe cases, it can also cause deadly hardening of internal organs ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Fibrocell Science announced in a press ...

SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics (NAS: CYTX) today announcedthat an investigator-sponsored and funded clinical study evaluating Cytori's cell therapy as a potential treatment for ...

Scleroderma is a chronic disorder manifested by excessive synthesis and deposition of collagen in skin and connective tissue, vascular abnormalities, and autoimmunity. Using microarray and real-time ...

Scleroderma with internal organ involvement is a debilitating and lethal autoimmune disorder with few effective treatments. But a study has now found new cause for optimism using an aggressive stem ...

Cyclophosphamide is widely used to treat severe manifestations of numerous autoimmune rheumatic diseases including systemic sclerosis. Based on recent data, immunological and inflammatory activation ...

In a bold attempt to control a disabling and often fatal immune disease called scleroderma, physicians at Duke University Medical Center are leading a national study to test whether stem cell ...

Not all patients with deterioration in pulmonary function tests have a progressive disease: 30% of patients develop progressive lung disease and only 16% will develop severe lung fibrosis (defined as ...